PCN97 Cost-Effectiveness of Atezolizumab Monotherapy Versus Pembrolizumab Monotherapy for First-Line Treatment of Metastatic Non-Small Cell Lung Cancer
Abstract
Authors
C.W. Lin K. Rosettie S.P. Bilir H. Celik S. Abogunrin S. Ogale